- Digital medicine company deepc announced it has raised €12 million in funding.
Digital medicine company deepc – a company that provides healthcare systems the flexibility to adopt and integrate third-party artificial intelligence (AI) technology into existing workflows and improve patient outcomes – announced that it has raised a €12 million Series A round led by Sofinnova Partners, which is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. These proceeds will be used to propel the commercialization of the deepcOS AI operating system and further develop streamlined services to improve the user experience for radiologists. Bertelsmann Investments and existing investor Winning Mindset Ventures also joined the round.
The company’s core technology deepcOS is a cloud-native and vendor-neutral platform that integrates seamlessly with existing radiology workflows. And it provides approved third-party AI vendors with an efficient way to commercialize their solutions while offering hospitals and clinics a secure one-stop shop for their AI-assisted radiology needs.
The proceeds are going to expand deepc’s geographic coverage and develop additional features within deepcOS. And the radiology teams will benefit as new AI-assisted options are seamlessly integrated into their workflows. Plus at the same time, AI software vendors are going to get low-friction access to a large number of potential customers.
KEY QUOTES:
“At deepc, we believe that AI has the power to revolutionize the way we approach healthcare, Our AI platform, deepcOS, is a game changer for radiology, allowing for faster, more accurate diagnoses and ultimately improving patient outcomes. We are thrilled to welcome Sofinnova Partners and Bertelsmann Investments on board. Their extensive networks in the healthcare ecosystem will propel deepc forward.”
— Dr. Franz Pfister, co-founder and CEO of deepc
“Our investment in deepc underscores our conviction that Digital Medicine holds enormous promise and that enabling technologies will be at the forefront of the digital revolution in healthcare, precisely the focus of our Digital Medicine investment strategy. deepcOS enables wide adoption of AI into a major part of the patient journey. The team has demonstrated the benefit that they can provide to healthcare professionals and patients.”
— Simon Turner, Partner at Sofinnova Partners
